Donald M. Engelman (born 1941) is Higgins Professor of Biochemistry at Yale University. He is a fellow of the American Academy of Arts and Sciences, a fellow of the National Institutes of Health, and has been a Guggenheim fellow. He is a director of the Stryker Corporation. He is involved in the creation of new cancer drugs and treatments. For example, Engelman is involved in research to use peptides to aid in destroying tumors.
Administration, Advising, and Consulting
Engelman has served as Director of Biological Sciences at Yale, an advisor to the Brookhaven National Laboratory, and a consultant to the Los Alamos National Laboratory. He also served as Acting Dean of Yale College in 1991.
Engelman directs the Engelman Laboratory at Yale.
- "All Fellows - John Simon Guggenheim Memorial Foundation". Gf.org. Retrieved 2011-07-06.
- "Donald M. Engelman Profile - Forbes.com". People.forbes.com. Retrieved 2011-07-06.
- "A Yale College Dean Is Named". The New York Times. 1991-10-15.
- "The Engelman Lab - Donald M. Engelman". Yale.edu. Retrieved 2011-07-06.
- "The Engelman Lab". Yale.edu. Retrieved 2011-07-06.